Global Paraneoplastic Pemphigus Market Overview:
Paraneoplastic pemphigus (PNP) is an autoimmune disorder arising from a pre-existing tumour. Paraneoplastic pemphigus is a newly recognised disease that was first recognized in 1990. It is assumed that antigens belonging to the tumour trigger an immune response resulting in blistering of the skin and mucous membranes. The earliest and most consistent symptom of this disease is severe inflammation of mucous of the mouth membrane. PNP can be mostly among the age group of 45 to 70 years old but also can be found in children and adolescents. Current treatment of Paraneoplastic Pemphigus focuses on wound healing and administering corticosteroids which has not shown a high success rate. New research developments in this field aim to treat an underlying tumour in order to heal the symptoms of PNP. Some of the players profiled in the study are Sanofi S.A. (France), Pfizer Inc. (United States), Amgen (United States), GSK Inc. (United Kingdom), Teva Pharmaceutical Industries (Israel), Novartis International AG (Switzerland), Principia Biopharma, Inc (United States) and Argenx (Netherlands).
On the basis of geography, the market of Paraneoplastic Pemphigus has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Therapy, the sub-segment i.e. High Dose Corticosteroids will boost the Paraneoplastic Pemphigus market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Medication, the sub-segment i.e. Prednisone will boost the Paraneoplastic Pemphigus market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Tumour, the sub-segment i.e. Malignant will boost the Paraneoplastic Pemphigus market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Diagnosis Tests, the sub-segment i.e. Microscopy will boost the Paraneoplastic Pemphigus market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Increasing World Population Results in High Occurrence of Paraneoplastic Pemphigus
- Sufficient Medical Infrastructure in Developed Nations
- Increasing Investment in Research of Treatment of Paraneoplastic Pemphigus
- High Cost Associated with Diagnosis and Medication of Paraneoplastic Pemphigus
- Increasing Institutional and Government-Backed Research in Finding Cure of Paraneoplastic Pemphigus
- Inability to Find Complete Cure of Paraneoplastic Pemphigus
- High R&D Costs Associated with Development of New Treatments of Paraneoplastic Pemphigus
Key Market Developments:
In Dec 2020, Amgen, a human therapeutics firm based in the US announced that the US food and drugs administration (FDA) has approved RIABNI a biosimilar to Rituxan for the treatment of adult patients with NHL, Chronic Lymphocytic Leukaemia, and other diseases. This drug is also designed to use for severe Mucocutaneous Reactions including Paraneoplastic Pemphigus which is fatal autoimmune disease caused by an immune response to functioning body part.
Paraneoplastic Pemphigus is a fatal disease and takes time to be diagnosed. The market to treat or medicate this disease is scattered and does not have any streamlined method. However, there is huge potential in treating this disease as the one player who can cure it, will make the money by licensing its technology to others. Paraneoplastic Pemphigus treating market is segmented in way of treatment, diagnosis, and containing the disease. There is no one distinct market leader in this field and the market is not matured. High R&D and expertise are essential to operate in this market.
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Paraneoplastic Pemphigus Treatment Products Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations, End-Use Industries and Others
Major Objectives Focused through this Study
To define, describe, and forecast the Global Paraneoplastic Pemphigus market on the basis of product  , application , key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Paraneoplastic Pemphigus market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Paraneoplastic Pemphigus industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Paraneoplastic Pemphigus market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.